Hepatocyte growth factor signaling ameliorates podocyte injury and proteinuria

Kidney International

Volumn 77, Issue 11, 2010, Pages 962-973

  Dai, Chunsun ^a   Saleem, Moin A ^b   Holzman, Lawrence B ^c   Mathieson, Peter ^d   Liu, Youhua ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

adriamycin nephropathy; c met; HGF; podocyte; proteinuria

Indexed keywords

DOXORUBICIN; NEPHRIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; WT1 PROTEIN; MEMBRANE PROTEIN;

ALBUMINURIA; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DAMAGE; CELL FUNCTION; CELL MATURATION; CELL REGENERATION; CELL SURVIVAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG MECHANISM; GENE TRANSFER; HOMEOSTASIS; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; SIGNAL TRANSDUCTION; AGE; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL CULTURE; CELL PROTECTION; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG EFFECT; GENETICS; KIDNEY DISEASE; METABOLISM; MOUSE MUTANT; PATHOLOGY; TIME;

1-PHOSPHATIDYLINOSITOL 3-KINASE; AGE FACTORS; ALBUMINURIA; ANIMALS; APOPTOSIS; CELLS, CULTURED; CYTOPROTECTION; DISEASE MODELS, ANIMAL; DOXORUBICIN; HEPATOCYTE GROWTH FACTOR; KIDNEY DISEASES; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; PODOCYTES; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-MET; SIGNAL TRANSDUCTION; TIME FACTORS; WT1 PROTEINS;

EID: 77955877135     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2010.40     Document Type: Article

References (47)

1. Liu Y. Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action. Am J Physiol Renal Physiol 2004; 287: F7-F16. (Pubitemid 38780577)
2. Mizuno S, Matsumoto K, Nakamura T. HGF as a renotrophic and antifibrotic regulator in chronic renal disease. Front Biosci 2008; 13: 7072-7086.
3. Mizuno S, Nakamura T. Suppressions of chronic glomerular injuries and TGF-beta1 production by HGF in attenuation of murine diabetic nephropathy. Am J Physiol Renal Physiol 2004; 286: F134-F143. (Pubitemid 38045051)
4. Dworkin LD, Gong R, Tolbert E et al. Hepatocyte growth factor ameliorates progression of interstitial fibrosis in rats with established renal injury. Kidney Int 2004; 65: 409-419. (Pubitemid 38130635)
5. Yang J, Liu Y. Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. J Am Soc Nephrol 2002; 13: 96-107. (Pubitemid 34042016)
6. Herrero-Fresneda I, Torras J, Franquesa M et al. HGF gene therapy attenuates renal allograft scarring by preventing the profibrotic inflammatory-induced mechanisms. Kidney Int 2006; 70: 265-274. (Pubitemid 44086576)
7. Azuma H, Takahara S, Matsumoto K et al. Hepatocyte growth factor prevents the development of chronic allograft nephropathy in rats. J Am Soc Nephrol 2001; 12: 1280-1292. (Pubitemid 32472643)
8. Dai C, Yang J, Bastacky S et al. Intravenous administration of hepatocyte growth factor gene ameliorates diabetic nephropathy in mice. J Am Soc Nephrol 2004; 15: 2637-2647. (Pubitemid 41103370)
9. Cruzado JM, Lloberas N, Torras J et al. Regression of advanced diabetic nephropathy by hepatocyte growth factor gene therapy in rats. Diabetes 2004; 53: 1119-1127. (Pubitemid 38436627)
10. Reddy GR, Kotlyarevska K, Ransom RF et al. The podocyte and diabetes mellitus: is the podocyte the key to the origins of diabetic nephropathy? Curr Opin Nephrol Hypertens 2008; 17: 32-36. (Pubitemid 350295194)
11. Wolf G, Ziyadeh FN. Cellular and molecular mechanisms of proteinuria in diabetic nephropathy. Nephron 2007; 106: 26-31.
12. Susztak K, Raff AC, Schiffer M et al. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 2006; 55: 225-233. (Pubitemid 43343319)
13. Pavenstadt H, Kriz W, Kretzler M. Cell biology of the glomerular podocyte. Physiol Rev 2003; 83: 253-307. (Pubitemid 36459882)
14. Huber TB, Benzing T. The slit diaphragm: a signaling platform to regulate podocyte function. Curr Opin Nephrol Hypertens 2005; 14: 211-216. (Pubitemid 40685631)
15. Wiggins RC. The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int 2007; 71: 1205-1214. (Pubitemid 46884251)
16. Shankland SJ. The podocyte's response to injury: role in proteinuria and glomerulosclerosis. Kidney Int 2006; 69: 2131-2147. (Pubitemid 43882099)
17. Li Y, Kang YS, Dai C et al. Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria. Am J Pathol 2008; 172: 299-308. (Pubitemid 351282018)
18. Yamaguchi Y, Iwano M, Suzuki D et al. Epithelial-mesenchymal transition as a potential explanation for podocyte depletion in diabetic nephropathy. Am J Kidney Dis 2009; 54: 653-664.
19. Zhang J, Yang J, Liu Y. Role of Bcl-xL induction in HGF-mediated renal epithelial cell survival after oxidant stress. Int J Clin Exp Pathol 2008; 1: 242-253.
20. Maulik G, Shrikhande A, Kijima T et al. Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition. Cytokine Growth Factor Rev 2002; 13: 41-59. (Pubitemid 34436961)
21. Zhang X, Li Y, Dai C et al. Sp1 and Sp3 transcription factors synergistically regulate HGF receptor gene expression in kidney. Am J Physiol Renal Physiol 2003; 284: F82-F94. (Pubitemid 35471288)
22. Wang Y, Wang YP, Tay YC et al. Progressive adriamycin nephropathy in mice: sequence of histologic and immunohistochemical events. Kidney Int 2000; 58: 1797-1804.
23. Morrison AA, Viney RL, Saleem MA et al. New insights into the function of the Wilms tumor suppressor gene WT1 in podocytes. Am J Physiol Renal Physiol 2008; 295: F12-F17.
24. Guo JK, Menke AL, Gubler MC et al. WT1 is a key regulator of podocyte function: reduced expression levels cause crescentic glomerulonephritis and mesangial sclerosis. Hum Mol Genet 2002; 11: 651-659. (Pubitemid 34285136)
25. Dai C, Yang J, Liu Y. Single injection of naked plasmid encoding hepatocyte growth factor prevents cell death and ameliorates acute renal failure in mice. J Am Soc Nephrol 2002; 13: 411-422. (Pubitemid 34106284)
26. Dai C, Liu Y. Hepatocyte growth factor antagonizes the profibrotic action of TGF-beta1 in mesangial cells by stabilizing Smad transcriptional corepressor TGIF. J Am Soc Nephrol 2004; 15: 1402-1412. (Pubitemid 38679665)
27. Wagner N, Wagner KD, Xing Y et al. The major podocyte protein nephrin is transcriptionally activated by the Wilms' tumor suppressor WT1. J Am Soc Nephrol 2004; 15: 3044-3051. (Pubitemid 39578836)
28. Guo G, Morrison DJ, Licht JD et al. WT1 activates a glomerular-specific enhancer identified from the human nephrin gene. J Am Soc Nephrol 2004; 15: 2851-2856. (Pubitemid 41103394)
29. Wiggins JE, Goyal M, Sanden SK et al. Podocyte hypertrophy, 'adaptation,' and 'decompensation' associated with glomerular enlargement and glomerulosclerosis in the aging rat: prevention by calorie restriction. J Am Soc Nephrol 2005; 16: 2953-2966. (Pubitemid 44743493)
30. Ishibe S, Karihaloo A, Ma H et al. Met and the epidermal growth factor receptor act cooperatively to regulate final nephron number and maintain collecting duct morphology. Development 2009; 136: 337-345.
31. Huh CG, Factor VM, Sanchez A et al. Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair. Proc Natl Acad Sci USA 2004; 101: 4477-4482. (Pubitemid 38437436)
32. Moeller MJ, Sanden SK, Soofi A et al. Podocyte-specific expression of cre recombinase in transgenic mice. Genesis 2003; 35: 39-42. (Pubitemid 36150980)
33. Jeansson M, Bjorck K, Tenstad O et al. Adriamycin alters glomerular endothelium to induce proteinuria. J Am Soc Nephrol 2009; 20: 114-122.
34. Dai C, Stolz DB, Kiss LP et al. Wnt/b-catenin signaling promotes podocyte dysfunction and albuminuria. J Am Soc Nephrol 2009; 20: 1997-2008.
35. Doublier S, Ruotsalainen V, Salvidio G et al. Nephrin redistribution on podocytes is a potential mechanism for proteinuria in patients with primary acquired nephrotic syndrome. Am J Pathol 2001; 158: 1723-1731. (Pubitemid 32422937)
36. Takano Y, Yamauchi K, Hiramatsu N et al. Recovery and maintenance of nephrin expression in cultured podocytes and identification of HGF as a repressor of nephrin. Am J Physiol Renal Physiol 2007; 292: F1573-F1582. (Pubitemid 46701885)
37. Yang J, Chen S, Huang L et al. Sustained expression of naked plasmid DNA encoding hepatocyte growth factor in mice promotes liver and overall body growth. Hepatology 2001; 33: 848-859. (Pubitemid 32246634)
38. Wharram BL, Goyal M, Wiggins JE et al. Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol 2005; 16: 2941-2952. (Pubitemid 44743492)
39. Fornoni A, Li H, Foschi A et al. Hepatocyte growth factor, but not insulinlike growth factor I, protects podocytes against cyclosporin A-induced apoptosis. Am J Pathol 2001; 158: 275-280. (Pubitemid 32096493)
40. Liu Y. Hepatocyte growth factor promotes renal epithelial cell survival by dual mechanisms. Am J Physiol 1999; 277: F624-F633. (Pubitemid 29526003)
41. Liu Y, Michalopoulos GK, Zarnegar R. Molecular cloning and characterization of cDNA encoding mouse hepatocyte growth factor. Biochim Biophys Acta 1993; 1216: 299-303. (Pubitemid 23344133)
42. Dai C, Huh CG, Thorgeirsson SS et al. b-cell-specific ablation of the hepatocyte growth factor receptor results in reduced islet size, impaired insulin secretion, and glucose intolerance. Am J Pathol 2005; 167: 429-436. (Pubitemid 43026099)
43. Dai C, Stolz DB, Bastacky SI et al. Essential role of integrin-linked kinase in podocyte biology: bridging the integrin and slit diaphragm signaling. J Am Soc Nephrol 2006; 17: 2164-2175. (Pubitemid 44141906)
44. Giannopoulou M, Dai C, Tan X et al. Hepatocyte growth factor exerts its anti-inflammatory action by disrupting nuclear factor-kB signaling. Am J Pathol 2008; 173: 30-41. (Pubitemid 351947953)
45. Takemoto M, Asker N, Gerhardt H et al. A new method for large scale isolation of kidney glomeruli from mice. Am J Pathol 2002; 161: 799-805. (Pubitemid 34988366)
46. Mundel P, Reiser J, Zuniga Mejia Borja A et al. Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp Cell Res 1997; 236: 248-258. (Pubitemid 27452369)
47. Saleem MA, O'Hare MJ, Reiser J et al. A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol 2002; 13: 630-638. (Pubitemid 34183927)